Basilea Pharmaceutica AG ( BPMUF) - Key Metrics
BPMUF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $9.57 | $2.25 | $1.53 | $1.49 |
| 2025Q4 | $10.53 | $2 | $3.20 | $3.01 |
| 2025Q2 | $8.31 | $1.26 | $1.84 | $1.82 |
| 2024Q4 | $10.94 | $4.70 | $4.67 | $4.56 |
| 2024Q2 | $5.94 | $1.61 | $1.39 | $1.36 |
BPMUF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 5.44 |
| 2025Q4 | 0% | 6.27 |
| 2025Q2 | 0% | 8.87 |
| 2024Q4 | 0% | 2.55 |
| 2024Q2 | 0% | 6.57 |
BPMUF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.06% | 0% |
| 2025Q4 | 6.00% | 0% |
| 2025Q2 | 3.97% | 0% |
| 2024Q4 | 9.51% | 0% |
| 2024Q2 | 3.21% | 0% |
BPMUF
Price: $76.25
52 week price:
Earnings Per Share: 3.93 USD
P/E Ratio: 19.69
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 943.7 million